Literature DB >> 17177422

Total synthesis and evaluation of cytostatin, its C10-C11 diastereomers, and additional key analogues: impact on PP2A inhibition.

Brian G Lawhorn1, Sobhana B Boga, Scott E Wolkenberg, David A Colby, Carla-Maria Gauss, Mark R Swingle, Lauren Amable, Richard E Honkanen, Dale L Boger.   

Abstract

The total synthesis of cytostatin, an antitumor agent belonging to the fostriecin family of natural products, is described in full detail. The convergent approach relied on a key epoxide-opening reaction to join the two stereotriad units and a single-step late-stage stereoselective installation of the sensitive (Z,Z,E)-triene through a beta-chelation-controlled nucleophilic addition. The synthetic route provided rapid access to the C4-C6 stereoisomers of the cytostatin lactone, which were prepared and used to define the C4-C6 relative stereochemistry of the natural product. In addition to the natural product, each of the C10-C11 diastereomers of cytostatin was divergently prepared (11 steps from key convergence step) by this route and used to unequivocally confirm the relative and absolute stereochemistry of cytostatin. Each of the cytostatin diastereomers exhibited a reduced activity toward inhibition of PP2A (>100-fold), demonstrating the importance of the presence and stereochemistry of the C10-methyl and C11-hydroxy groups for potent PP2A inhibition. Extensions of the studies provided dephosphocytostatin, sulfocytostatin (a key analogue related to the natural product sultriecin), 11-deshydroxycytostatin, and an analogue lacking the entire C12-C18 (Z,Z,E)-triene segment, which were used to define the magnitude of the C9-phosphate (>4000-fold), C11-alcohol (250-fold), and triene (220-fold) contribution to PP2A inhibition. A model of cytostatin bound to the active site of PP2A is presented, compared to that of fostriecin, which is also presented in detail for the first time, and used to provide insights into the role of the key substituents. Notably, the alpha,beta unsaturated lactone of cytostatin, like that of fostriecin, is projected to serve as a key electrophile, providing a covalent adduct with Cys269 unique to PP2A, contributing to its potency (> or =200-fold for fostriecin) and accounting for its selectivity.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17177422      PMCID: PMC2566737          DOI: 10.1021/ja066477d

Source DB:  PubMed          Journal:  J Am Chem Soc        ISSN: 0002-7863            Impact factor:   15.419


  46 in total

1.  Protein phosphatase 2A inhibition induces cerebellar long-term depression and declustering of synaptic AMPA receptor.

Authors:  T Launey; S Endo; R Sakai; J Harano; M Ito
Journal:  Proc Natl Acad Sci U S A       Date:  2003-12-29       Impact factor: 11.205

2.  Isolation and structure of phosphazomycin C.

Authors:  T Tomiya; M Uramoto; K Isono
Journal:  J Antibiot (Tokyo)       Date:  1990-01       Impact factor: 2.649

3.  Mutational analysis of substrate recognition by protein phosphatase 1.

Authors:  L Zhang; E Y Lee
Journal:  Biochemistry       Date:  1997-07-08       Impact factor: 3.162

4.  Screening for apoptosis inducers in microbial products and induction of apoptosis by cytostatin.

Authors:  K Yamazaki; M Amemiya; M Ishizuka; T Takeuchi
Journal:  J Antibiot (Tokyo)       Date:  1995-10       Impact factor: 2.649

5.  Phoslactomycin targets cysteine-269 of the protein phosphatase 2A catalytic subunit in cells.

Authors:  Takayuki Teruya; Siro Simizu; Naoki Kanoh; Hiroyuki Osada
Journal:  FEBS Lett       Date:  2005-04-25       Impact factor: 4.124

6.  Total synthesis of fostriecin (CI-920).

Authors:  D L Boger; S Ichikawa; W Zhong
Journal:  J Am Chem Soc       Date:  2001-05-09       Impact factor: 15.419

7.  Fostriecin-mediated G2-M-phase growth arrest correlates with abnormal centrosome replication, the formation of aberrant mitotic spindles, and the inhibition of serine/threonine protein phosphatase activity.

Authors:  A Cheng; R Balczon; Z Zuo; J S Koons; A H Walsh; R E Honkanen
Journal:  Cancer Res       Date:  1998-08-15       Impact factor: 12.701

8.  Total synthesis and biological evaluation of the protein phosphatase 2A inhibitor cytostatin and analogues.

Authors:  Laurent Bialy; Herbert Waldmann
Journal:  Chemistry       Date:  2004-06-07       Impact factor: 5.236

Review 9.  Fostriecin: chemistry and biology.

Authors:  D S Lewy; C-M Gauss; D R Soenen; D L Boger
Journal:  Curr Med Chem       Date:  2002-11       Impact factor: 4.530

10.  Differential induction of apoptosis in B16 melanoma and EL-4 lymphoma cells by cytostatin and bactobolin.

Authors:  M Kawada; M Amemiya; M Ishizuka; T Takeuchi
Journal:  Jpn J Cancer Res       Date:  1999-02
View more
  14 in total

1.  Formation of α-chiral centers by asymmetric β-C(sp3)-H arylation, alkenylation, and alkynylation.

Authors:  Qing-Feng Wu; Peng-Xiang Shen; Jian He; Xiao-Bing Wang; Forrest Zhang; Qian Shao; Ru-Yi Zhu; Claudio Mapelli; Jennifer X Qiao; Michael A Poss; Jin-Quan Yu
Journal:  Science       Date:  2017-02-03       Impact factor: 47.728

Review 2.  Synthetic Strategies Employed for the Construction of Fostriecin and Related Natural Products.

Authors:  Barry M Trost; Joshua D Knopf; Cheyenne S Brindle
Journal:  Chem Rev       Date:  2016-12-08       Impact factor: 60.622

3.  The Antitumor Drug LB-100 Is a Catalytic Inhibitor of Protein Phosphatase 2A (PPP2CA) and 5 (PPP5C) Coordinating with the Active-Site Catalytic Metals in PPP5C.

Authors:  Brandon M D'Arcy; Mark R Swingle; Cinta M Papke; Kevin A Abney; Erin S Bouska; Aishwarya Prakash; Richard E Honkanen
Journal:  Mol Cancer Ther       Date:  2019-01-24       Impact factor: 6.261

4.  Total synthesis of fostriecin: via a regio- and stereoselective polyene hydration, oxidation, and hydroboration sequence.

Authors:  Dong Gao; George A O'Doherty
Journal:  Org Lett       Date:  2010-09-03       Impact factor: 6.005

Review 5.  De novo synthesis of natural products via the asymmetric hydration of polyenes.

Authors:  Yanping Wang; Yalan Xing; Qi Zhang; George A O'Doherty
Journal:  Chem Commun (Camb)       Date:  2011-05-11       Impact factor: 6.222

6.  Enantioselective hydroformylation of N-vinyl carboxamides, allyl carbamates, and allyl ethers using chiral diazaphospholane ligands.

Authors:  Richard I McDonald; Gene W Wong; Ram P Neupane; Shannon S Stahl; Clark R Landis
Journal:  J Am Chem Soc       Date:  2010-10-13       Impact factor: 15.419

7.  Structure-activity relationship studies of fostriecin, cytostatin, and key analogs, with PP1, PP2A, PP5, and( beta12-beta13)-chimeras (PP1/PP2A and PP5/PP2A), provide further insight into the inhibitory actions of fostriecin family inhibitors.

Authors:  Mark R Swingle; Lauren Amable; Brian G Lawhorn; Suzanne B Buck; Christopher P Burke; Pukar Ratti; Kimberly L Fischer; Dale L Boger; Richard E Honkanen
Journal:  J Pharmacol Exp Ther       Date:  2009-07-10       Impact factor: 4.030

8.  Suppression of Ser/Thr phosphatase 4 (PP4C/PPP4C) mimics a novel post-mitotic action of fostriecin, producing mitotic slippage followed by tetraploid cell death.

Authors:  Benjamin Theobald; Kathy Bonness; Alla Musiyenko; Joel F Andrews; Gudrun Urban; Xizhong Huang; Nicholas M Dean; Richard E Honkanen
Journal:  Mol Cancer Res       Date:  2013-05-13       Impact factor: 5.852

9.  cis-Delta(2,3)-double bond of phoslactomycins is generated by a post-PKS tailoring enzyme.

Authors:  Nadaraj Palaniappan; Mamoun M Alhamadsheh; Kevin A Reynolds
Journal:  J Am Chem Soc       Date:  2008-08-21       Impact factor: 15.419

10.  Total synthesis, assignment of the relative and absolute stereochemistry, and structural reassignment of phostriecin (aka Sultriecin).

Authors:  Christopher P Burke; Nadia Haq; Dale L Boger
Journal:  J Am Chem Soc       Date:  2010-02-24       Impact factor: 15.419

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.